Company’s history |
 |
|
Further to the call for projects issued
by LyonBiopole-Mérial, the company PX’Monoclonals
has been created
in July 2007 and will propose custom research and production
services
in the monoclonal antibody field by October 2007. |
|
A technology platform |
|
|
Based in Lyon, PX’Monoclonals will offer services ranging from
the generation of high affinity
murine antibodies for research
and diagnostics applications to the development of humanized
and
human antibodies for therapeutic purposes. In order to develop
a competitive technology
platform and to propose innovative approaches,
PX’Monoclonals will also initiate internal R&D programmes in
collaboration with Biotech companies and academic laboratories. |
|
Management team |
|
|
PX’Monoclonals is a subsidiary of the company
Protein’eXpert and will therefore benefit from
its experience in
terms of enterprise development, technology platform management
and commercialization of research services. |
| |
|
|
 |
| |
|
|
Protein'eXpert's profile
Funded in 2000 in Grenoble, France,
Protein'eXpert is
an expanding Contract Research & Manufacturing
Organisation devoted to recombinant protein engineering
& production for biomedical research applications.
The 40-staff
company offers custom-designed services focusing on the discovery,
optimisation and production of valuable target or therapeutic
proteins. Recognised as a leading European player in the field
of recombinant proteins manufacturing, Protein'eXpert has extented
its offering to the biomanufacturing of therapeutic protein
products for early clinicals trials via its integrated subsidiary
PX'Pharma in 2004. PX'Pharma provides dedicated contract services
for process development & scale-up optimisation, pre-clinical
and clinical cGMP production. |
|
|
|
